Table 4 Clinical features of SCC transformation in MCTO

Age, years (n = 434)^a

53.5 (13.9, 19–87)

<45 years

121

≥45 years

313

Tumor size, cm (n = 316)^a

14.8 (5.9, 3.5–40)

SCC-Ag, ng/mL (n = 78)

7.4 (3.0, 20.0)

CA125, U/mL(n = 104)

64.4 (34.2, 143.0)

CA19–9,U/mL (n = 65)

144.0 (45.1, 943.5)

CEA, ng/mL (n = 51)

6.9 (2.5, 23.0)

Abdominal/pelvic pain

139

Mass

53

Abdominal bloating

49

Physical examination

10

Urinary frequency

6

Weight loss

11

Change in bowel habits

20

Fever

7

I

207

II

78

III

111

IV

18

1

54

2

84

3

65